NO943042L - Farmasöytiske sammensetninger - Google Patents

Farmasöytiske sammensetninger

Info

Publication number
NO943042L
NO943042L NO943042A NO943042A NO943042L NO 943042 L NO943042 L NO 943042L NO 943042 A NO943042 A NO 943042A NO 943042 A NO943042 A NO 943042A NO 943042 L NO943042 L NO 943042L
Authority
NO
Norway
Prior art keywords
group
substituted
hydrogen
represents hydrogen
halogeno
Prior art date
Application number
NO943042A
Other languages
English (en)
Other versions
NO943042D0 (no
NO305027B1 (no
Inventor
Edward Andrew Boyd
Brenda Costall
Elisabeth Mary Kelly
Philip James Parsons
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929203500A external-priority patent/GB9203500D0/en
Application filed by British Tech Group filed Critical British Tech Group
Publication of NO943042L publication Critical patent/NO943042L/no
Publication of NO943042D0 publication Critical patent/NO943042D0/no
Publication of NO305027B1 publication Critical patent/NO305027B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO943042A 1992-02-19 1994-08-17 Farmas°ytiske sammensetninger NO305027B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929203500A GB9203500D0 (en) 1992-02-19 1992-02-19 Pharmaceutical compositions
GB9300921A GB2264299B (en) 1992-02-19 1993-01-19 Iso-oxazolidine derivatives
PCT/GB1993/000334 WO1993017004A1 (en) 1992-02-19 1993-02-18 Benzisoxazole derivatives and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NO943042L true NO943042L (no) 1994-08-17
NO943042D0 NO943042D0 (no) 1994-08-17
NO305027B1 NO305027B1 (no) 1999-03-22

Family

ID=26300339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943042A NO305027B1 (no) 1992-02-19 1994-08-17 Farmas°ytiske sammensetninger

Country Status (16)

Country Link
US (2) US5476867A (no)
EP (1) EP0626951B1 (no)
JP (1) JP3464479B2 (no)
KR (1) KR100274479B1 (no)
AT (1) ATE169010T1 (no)
AU (1) AU677176B2 (no)
CA (1) CA2117471C (no)
DE (1) DE69320030T2 (no)
DK (1) DK0626951T3 (no)
ES (1) ES2121075T3 (no)
GB (1) GB2264299B (no)
IL (1) IL104771A (no)
NO (1) NO305027B1 (no)
PH (1) PH31392A (no)
WO (1) WO1993017004A1 (no)
ZA (1) ZA931190B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226857D0 (en) * 1992-12-23 1993-02-17 Boyd Edward A Pharmaceutical compositions
US7115666B2 (en) * 2002-10-15 2006-10-03 Renovis, Inc. Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
MXPA05013464A (es) * 2003-06-12 2006-03-17 Btg Int Ltd Hidroxilamina ciclica como compuestos psicoactivos.
ITMI20062102A1 (it) * 2006-11-02 2008-05-03 Abiogen Pharma Spa Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one
EP2112142A1 (en) * 2008-04-24 2009-10-28 Abiogen Pharma S.p.A. Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
ITMI20080768A1 (it) * 2008-04-24 2009-10-25 Abiogen Pharma Spa Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one
WO2011010332A1 (en) * 2009-07-23 2011-01-27 Abiogen Pharma S.P.A. Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1540580A (en) * 1975-09-02 1979-02-14 Shell Int Research Fungicidal isoxazolidines
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
US5114960A (en) * 1989-07-20 1992-05-19 Hoffmann-La Roche Inc. Substituted isoxazole derivatives
US5114936A (en) * 1990-08-23 1992-05-19 Hoechst-Roussel Pharmaceuticals Incorporated 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use

Also Published As

Publication number Publication date
KR950700264A (ko) 1995-01-16
DE69320030T2 (de) 1998-12-10
GB2264299A (en) 1993-08-25
IL104771A0 (en) 1994-05-30
ZA931190B (en) 1994-08-19
JP3464479B2 (ja) 2003-11-10
DK0626951T3 (da) 1999-02-15
ES2121075T3 (es) 1998-11-16
EP0626951A1 (en) 1994-12-07
EP0626951B1 (en) 1998-07-29
NO943042D0 (no) 1994-08-17
US5476867A (en) 1995-12-19
CA2117471C (en) 2003-04-22
US5578626A (en) 1996-11-26
GB9300921D0 (en) 1993-03-10
KR100274479B1 (ko) 2000-12-15
IL104771A (en) 1998-07-15
NO305027B1 (no) 1999-03-22
AU677176B2 (en) 1997-04-17
JPH07504181A (ja) 1995-05-11
PH31392A (en) 1998-10-29
ATE169010T1 (de) 1998-08-15
CA2117471A1 (en) 1993-09-02
WO1993017004A1 (en) 1993-09-02
DE69320030D1 (de) 1998-09-03
GB2264299B (en) 1995-07-26
AU3508693A (en) 1993-09-13

Similar Documents

Publication Publication Date Title
FI884350A (fi) Som antagonister nyttiga nya benzimidazolin-2-oxo-1-karboxylsyraderivat av 5-ht reseptor.
DE69428142D1 (de) Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung
NO943042D0 (no) Farmasöytiske sammensetninger
ES8200669A1 (es) Un procedimiento para la preparacion de nuevos compuestos iminicos heterociclicos
IL108135A0 (en) Pharmaceutical compositions containing benzoisoxazoles
ATE89818T1 (de) Dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees